2-Aminoquinoline structure
|
Common Name | 2-Aminoquinoline | ||
|---|---|---|---|---|
| CAS Number | 580-22-3 | Molecular Weight | 144.17 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 304.9±15.0 °C at 760 mmHg | |
| Molecular Formula | C9H8N2 | Melting Point | 125 °C | |
| MSDS | Chinese USA | Flash Point | 163.6±7.6 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
Use of 2-Aminoquinoline2-Aminoquinoline is a promising compound as bioavailable nNOS inhibitor but suffers from low human nNOS inhibition, low selectivity versus human eNOS, and significant binding to other CNS targets. 2-Aminoquinoline has the potential for the research of antineurodegenerative agents[1]. |
| Name | 2-Aminoquinoline |
|---|---|
| Synonym | More Synonyms |
| Description | 2-Aminoquinoline is a promising compound as bioavailable nNOS inhibitor but suffers from low human nNOS inhibition, low selectivity versus human eNOS, and significant binding to other CNS targets. 2-Aminoquinoline has the potential for the research of antineurodegenerative agents[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 304.9±15.0 °C at 760 mmHg |
| Melting Point | 125 °C |
| Molecular Formula | C9H8N2 |
| Molecular Weight | 144.17 |
| Flash Point | 163.6±7.6 °C |
| Exact Mass | 144.068741 |
| PSA | 38.91000 |
| LogP | 1.73 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.708 |
| Water Solubility | soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H315-H318-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R20/21/22;R36/37/38 |
| Safety Phrases | S26-S36/37/39-S22 |
| RIDADR | NONH for all modes of transport |
| RTECS | VA9621800 |
| HS Code | 2933499090 |
| Precursor 8 | |
|---|---|
| DownStream 8 | |
| HS Code | 2933499090 |
|---|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Synthesis and evaluation of the anti-nociceptive and anti-inflammatory activity of 4-aminoquinoline derivatives.
Bioorg. Med. Chem. 23 , 4390-6, (2015) In this paper, we describe the synthesis and pharmacological evaluation of a series of 4-aminoquinolines. The compounds were characterised and tested in models of pain and inflammation, using the writ... |
| MFCD00038079 |
| 2(1H)-Quinolinimine |
| 2-Aminoquindine |
| EINECS 209-458-8 |
| 2-Quinolinamine |
| iminoquinoline |
| quinolin-2-amine |